Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma.
Peng, Jian-Heng; Zhang, Xiang; Song, Jun-Long; Ran, Liang; Luo, Rong; Li, Hong-Yuan; Wang, Yong-Hong.
Afiliação
  • Peng JH; Health Management Center, The First Affiliated Hospital of Chongqing Medical University.
  • Zhang X; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing.
  • Song JL; Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
  • Ran L; Health Management Center, The First Affiliated Hospital of Chongqing Medical University.
  • Luo R; Health Management Center, The First Affiliated Hospital of Chongqing Medical University.
  • Li HY; Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing.
  • Wang YH; Health Management Center, The First Affiliated Hospital of Chongqing Medical University.
Medicine (Baltimore) ; 98(2): e13554, 2019 01.
Article em En | MEDLINE | ID: mdl-30633152
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Ductal de Mama Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Ductal de Mama Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article